Meeting
2022 ASCO Annual Meeting
An ultrasensitive approach for cancer screening and tissue of origin prediction based on targeted methylation sequencing of cell-free DNA.
Authors
Tiancheng Han
Genecast Biotechnology Co., Ltd., Wuxi, China
Tiancheng Han , Tianshu Liu , Li Suxing , Xi Li , Qi Zhang , Jianing Yu , Yuanyuan Hong , Yulong LI , Yu S. Huang , Ji He , Weizhi Chen , Yiyi Yu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10553)
DOI
10.1200/JCO.2022.40.16_suppl.10553
Abstract #
10553
Poster Bd #
429
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Discovery of a core-panel of markers for a blood-assay for cancer detection utilizing cfDNA methylation changes.
First Author: Lasika Seneviratne
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Enhanced blood-based colorectal cancer screening with improved performance in detection of early stage disease.
First Author: Sven Duenwald
Poster
2023 ASCO Breakthrough
The challenge of colorectal cancer (CRC) screening in low and middle-income countries (LMIC): The Brazilian ten year long experience.
First Author: Victor Filogonio
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Use of methylation and fragmentation signals in the detection of early-stage colorectal cancer.
First Author: Pol Canal-Noguer